Key points are not available for this paper at this time.
Allogeneic hematopoietic cell transplantation (HCT) improves outcomes for patients with AML harboring an internal tandem duplication mutation of
Share your take
Add a clinician perspective alongside expert commentary.
Levis et al. (Tue,) studied this question.